Outpatient Antibiotic Use in Europe and Association with Resistance.

1. The LANCET Volume 365, Number 9459 12 February 2005 Outpatient Antibiotic Use in Europe and Association with Resistance. Herman Goossens, M.D., Ph.D., Matus Ferech, Pharm.D., Robert Vander Stichele, M.D., , Monique Elseviers, Ph.D, and the ESAC Project Group. From the ESAC Management Team, Department of Microbiology, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium Address for correspondence: Prof. Dr. H. Goossens Department of Microbiology, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium Tel (+) 32 3 821 3789 Fax (+) 32 3 825 4281 E-mail: Herman.Goossens@uza.be

2. Figure 1 Total Outpatient antibiotic use in 26 European countries in 2002

3. Figure 2 Seasonal variation of total outpatient antibiotic use in 10 European countries

4. Figure 3 Outpatient use of penicillins (J01C) in 26 European countries in 2002 in descending order of narrow spectrum penicillins

5. Figure 5 Outpatient use of the third generation Cephalosporins in 2002

6. Figure 6 Outpatient use of Macrolides, Lincosamides and Streptogramins (J01F) in 26 European countries in 2002

7. Figure 7 Outpatient use of Quinolones (J01M) in 26 European countries in 2002